Dreman Value Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | $3K | Hold |
161
| – | – | ﹤0.01% | 451 |
|
|
2017
Q4 | $3K | Sell |
161
-41,887
| -100% | -$781K | ﹤0.01% | 443 |
|
|
2017
Q3 | $740K | Sell |
42,048
-2,390
| -5% | -$42.1K | 0.41% | 82 |
|
|
2017
Q2 | $1.48M | Buy |
44,438
+28,792
| +184% | +$956K | 0.81% | 33 |
|
|
2017
Q1 | $502K | Sell |
15,646
-1,105
| -7% | -$35.5K | 0.29% | 121 |
|
|
2016
Q4 | $607K | Sell |
16,751
-15,218
| -48% | -$551K | 0.34% | 78 |
|
|
2016
Q3 | $1.47M | Sell |
31,969
-1,305
| -4% | -$60K | 0.89% | 34 |
|
|
2016
Q2 | $1.67M | Sell |
33,274
-709
| -2% | -$35.6K | 1.03% | 30 |
|
|
2016
Q1 | $1.82M | Buy |
+33,983
| New | +$1.82M | 0.21% | 134 |
|
|
2015
Q4 | – | Sell |
-42,892
| Closed | -$2.42M | – | 389 |
|
|
2015
Q3 | $2.42M | Sell |
42,892
-47,453
| -53% | -$2.68M | 0.24% | 115 |
|
|
2015
Q2 | $5.34M | Sell |
90,345
-9,788
| -10% | -$578K | 0.44% | 79 |
|
|
2015
Q1 | $6.24M | Sell |
100,133
-19,705
| -16% | -$1.23M | 0.54% | 66 |
|
|
2014
Q4 | $6.89M | Sell |
119,838
-37,611
| -24% | -$2.16M | 0.57% | 56 |
|
|
2014
Q3 | $8.46M | Sell |
157,449
-1,641
| -1% | -$88.2K | 0.69% | 36 |
|
|
2014
Q2 | $8.34M | Sell |
159,090
-24,233
| -13% | -$1.27M | 0.63% | 49 |
|
|
2014
Q1 | $9.69M | Buy |
183,323
+35,995
| +24% | +$1.9M | 0.75% | 28 |
|
|
2013
Q4 | $9.03M | Sell |
147,328
-17,636
| -11% | -$1.08M | 0.68% | 36 |
|
|
2013
Q3 | $6.23M | Buy |
+164,964
| New | +$6.23M | 0.56% | 90 |
|